Total Revenue: $15.4B Founded Year: 1916 Total Employees: 29,900 Headquarters: Melbourne, Australia Market Cap: $47.64B Stock Exchange: ASX CSL is a global biotechnology company focused on developing and delivering plasma-derived therapies, vaccines, and specialty medicines, operating through key segments like CSL Behring, CSL Seqirus, and CSL Vifor collectively addressing rare diseases, immunology, and infectious diseases
5 Persistence and discontinuation Persistence with GLP-1 therapy has been a major concern
If a GLP-1 prescription is in your medicine cabinet, you know all about it
Formulated with five novel, next-gen strains, Metabolic Daily uses the same powerful strains of Pendulums flagship product, Glucose Control , but at a dose that benefits metabolic health at a lower price
Pre-clinical evaluation of a modified cyclodextrin-based nanoparticle for intestinal delivery of liraglutide